Covid-19 Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Covid-19 Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Covid-19 Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Covid-19 Treatment Overall Market Size
2.1 Global Covid-19 Treatment Market Size: 2021 VS 2028
2.2 Global Covid-19 Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Covid-19 Treatment Players in Global Market
3.2 Top Global Covid-19 Treatment Companies Ranked by Revenue
3.3 Global Covid-19 Treatment Revenue by Companies
3.4 Top 3 and Top 5 Covid-19 Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Covid-19 Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Covid-19 Treatment Players in Global Market
3.6.1 List of Global Tier 1 Covid-19 Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Covid-19 Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Covid-19 Treatment Market Size Markets, 2021 & 2028
4.1.2 Respiratory Support
4.1.3 Circulatory Support.
4.1.4 Convalescent Plasma Therapy
4.1.5 Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin)
4.1.6 Antimicrobial Therapy
4.1.7 Renal Failure and Renal Replacement Therapy
4.1.8 Lung Replacement Therapy
4.1.9 Immunotherapy
4.1.10 Other therapeutic measures
4.2 By Type - Global Covid-19 Treatment Revenue & Forecasts
4.2.1 By Type - Global Covid-19 Treatment Revenue, 2017-2022
4.2.2 By Type - Global Covid-19 Treatment Revenue, 2023-2028
4.2.3 By Type - Global Covid-19 Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Covid-19 Treatment Market Size, 2021 & 2028
5.1.2 Children
5.1.3 Adult
5.1.4 Special Groups
5.2 By Application - Global Covid-19 Treatment Revenue & Forecasts
5.2.1 By Application - Global Covid-19 Treatment Revenue, 2017-2022
5.2.2 By Application - Global Covid-19 Treatment Revenue, 2023-2028
5.2.3 By Application - Global Covid-19 Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Covid-19 Treatment Market Size, 2021 & 2028
6.2 By Region - Global Covid-19 Treatment Revenue & Forecasts
6.2.1 By Region - Global Covid-19 Treatment Revenue, 2017-2022
6.2.2 By Region - Global Covid-19 Treatment Revenue, 2023-2028
6.2.3 By Region - Global Covid-19 Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Covid-19 Treatment Revenue, 2017-2028
6.3.2 US Covid-19 Treatment Market Size, 2017-2028
6.3.3 Canada Covid-19 Treatment Market Size, 2017-2028
6.3.4 Mexico Covid-19 Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Covid-19 Treatment Revenue, 2017-2028
6.4.2 Germany Covid-19 Treatment Market Size, 2017-2028
6.4.3 France Covid-19 Treatment Market Size, 2017-2028
6.4.4 U.K. Covid-19 Treatment Market Size, 2017-2028
6.4.5 Italy Covid-19 Treatment Market Size, 2017-2028
6.4.6 Russia Covid-19 Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Covid-19 Treatment Market Size, 2017-2028
6.4.8 Benelux Covid-19 Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Covid-19 Treatment Revenue, 2017-2028
6.5.2 China Covid-19 Treatment Market Size, 2017-2028
6.5.3 Japan Covid-19 Treatment Market Size, 2017-2028
6.5.4 South Korea Covid-19 Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Covid-19 Treatment Market Size, 2017-2028
6.5.6 India Covid-19 Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Covid-19 Treatment Revenue, 2017-2028
6.6.2 Brazil Covid-19 Treatment Market Size, 2017-2028
6.6.3 Argentina Covid-19 Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Covid-19 Treatment Revenue, 2017-2028
6.7.2 Turkey Covid-19 Treatment Market Size, 2017-2028
6.7.3 Israel Covid-19 Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Covid-19 Treatment Market Size, 2017-2028
6.7.5 UAE Covid-19 Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Applied DNA Sciences, Inc
7.1.1 Applied DNA Sciences, Inc Corporate Summary
7.1.2 Applied DNA Sciences, Inc Business Overview
7.1.3 Applied DNA Sciences, Inc Covid-19 Treatment Major Product Offerings
7.1.4 Applied DNA Sciences, Inc Covid-19 Treatment Revenue in Global Market (2017-2022)
7.1.5 Applied DNA Sciences, Inc Key News
7.2 Codagenix
7.2.1 Codagenix Corporate Summary
7.2.2 Codagenix Business Overview
7.2.3 Codagenix Covid-19 Treatment Major Product Offerings
7.2.4 Codagenix Covid-19 Treatment Revenue in Global Market (2017-2022)
7.2.5 Codagenix Key News
7.3 GeoVax Labs, Inc.
7.3.1 GeoVax Labs, Inc. Corporate Summary
7.3.2 GeoVax Labs, Inc. Business Overview
7.3.3 GeoVax Labs, Inc. Covid-19 Treatment Major Product Offerings
7.3.4 GeoVax Labs, Inc. Covid-19 Treatment Revenue in Global Market (2017-2022)
7.3.5 GeoVax Labs, Inc. Key News
7.4 Takis Biotech
7.4.1 Takis Biotech Corporate Summary
7.4.2 Takis Biotech Business Overview
7.4.3 Takis Biotech Covid-19 Treatment Major Product Offerings
7.4.4 Takis Biotech Covid-19 Treatment Revenue in Global Market (2017-2022)
7.4.5 Takis Biotech Key News
7.5 Evvivax
7.5.1 Evvivax Corporate Summary
7.5.2 Evvivax Business Overview
7.5.3 Evvivax Covid-19 Treatment Major Product Offerings
7.5.4 Evvivax Covid-19 Treatment Revenue in Global Market (2017-2022)
7.5.5 Evvivax Key News
7.6 Zydus Cadila
7.6.1 Zydus Cadila Corporate Summary
7.6.2 Zydus Cadila Business Overview
7.6.3 Zydus Cadila Covid-19 Treatment Major Product Offerings
7.6.4 Zydus Cadila Covid-19 Treatment Revenue in Global Market (2017-2022)
7.6.5 Zydus Cadila Key News
7.7 MIGAL Galilee Research Institute
7.7.1 MIGAL Galilee Research Institute Corporate Summary
7.7.2 MIGAL Galilee Research Institute Business Overview
7.7.3 MIGAL Galilee Research Institute Covid-19 Treatment Major Product Offerings
7.7.4 MIGAL Galilee Research Institute Covid-19 Treatment Revenue in Global Market (2017-2022)
7.7.5 MIGAL Galilee Research Institute Key News
7.8 Generex Biotechnology Corporation
7.8.1 Generex Biotechnology Corporation Corporate Summary
7.8.2 Generex Biotechnology Corporation Business Overview
7.8.3 Generex Biotechnology Corporation Covid-19 Treatment Major Product Offerings
7.8.4 Generex Biotechnology Corporation Covid-19 Treatment Revenue in Global Market (2017-2022)
7.8.5 Generex Biotechnology Corporation Key News
7.9 Moderna Therapeutics
7.9.1 Moderna Therapeutics Corporate Summary
7.9.2 Moderna Therapeutics Business Overview
7.9.3 Moderna Therapeutics Covid-19 Treatment Major Product Offerings
7.9.4 Moderna Therapeutics Covid-19 Treatment Revenue in Global Market (2017-2022)
7.9.5 Moderna Therapeutics Key News
7.10 Novavax
7.10.1 Novavax Corporate Summary
7.10.2 Novavax Business Overview
7.10.3 Novavax Covid-19 Treatment Major Product Offerings
7.10.4 Novavax Covid-19 Treatment Revenue in Global Market (2017-2022)
7.10.5 Novavax Key News
7.11 Bravovax
7.11.1 Bravovax Corporate Summary
7.11.2 Bravovax Business Overview
7.11.3 Bravovax Covid-19 Treatment Major Product Offerings
7.11.4 Bravovax Covid-19 Treatment Revenue in Global Market (2017-2022)
7.11.5 Bravovax Key News
7.12 Ascletis Pharma
7.12.1 Ascletis Pharma Corporate Summary
7.12.2 Ascletis Pharma Business Overview
7.12.3 Ascletis Pharma Covid-19 Treatment Major Product Offerings
7.12.4 Ascletis Pharma Covid-19 Treatment Revenue in Global Market (2017-2022)
7.12.5 Ascletis Pharma Key News
7.13 Janssen Pharmaceuticals
7.13.1 Janssen Pharmaceuticals Corporate Summary
7.13.2 Janssen Pharmaceuticals Business Overview
7.13.3 Janssen Pharmaceuticals Covid-19 Treatment Major Product Offerings
7.13.4 Janssen Pharmaceuticals Covid-19 Treatment Revenue in Global Market (2017-2022)
7.13.5 Janssen Pharmaceuticals Key News
7.14 Altimmune
7.14.1 Altimmune Corporate Summary
7.14.2 Altimmune Business Overview
7.14.3 Altimmune Covid-19 Treatment Major Product Offerings
7.14.4 Altimmune Covid-19 Treatment Revenue in Global Market (2017-2022)
7.14.5 Altimmune Key News
7.15 Greffex Inc.
7.15.1 Greffex Inc. Corporate Summary
7.15.2 Greffex Inc. Business Overview
7.15.3 Greffex Inc. Covid-19 Treatment Major Product Offerings
7.15.4 Greffex Inc. Covid-19 Treatment Revenue in Global Market (2017-2022)
7.15.5 Greffex Inc. Key News
7.16 CanSino Biologics, Inc.
7.16.1 CanSino Biologics, Inc. Corporate Summary
7.16.2 CanSino Biologics, Inc. Business Overview
7.16.3 CanSino Biologics, Inc. Covid-19 Treatment Major Product Offerings
7.16.4 CanSino Biologics, Inc. Covid-19 Treatment Revenue in Global Market (2017-2022)
7.16.5 CanSino Biologics, Inc. Key News
7.17 ExpreS2ion Biotechnologies ApS
7.17.1 ExpreS2ion Biotechnologies ApS Corporate Summary
7.17.2 ExpreS2ion Biotechnologies ApS Business Overview
7.17.3 ExpreS2ion Biotechnologies ApS Covid-19 Treatment Major Product Offerings
7.17.4 ExpreS2ion Biotechnologies ApS Covid-19 Treatment Revenue in Global Market (2017-2022)
7.17.5 ExpreS2ion Biotechnologies ApS Key News
7.18 Clover Biopharmaceuticals
7.18.1 Clover Biopharmaceuticals Corporate Summary
7.18.2 Clover Biopharmaceuticals Business Overview
7.18.3 Clover Biopharmaceuticals Covid-19 Treatment Major Product Offerings
7.18.4 Clover Biopharmaceuticals Covid-19 Treatment Revenue in Global Market (2017-2022)
7.18.5 Clover Biopharmaceuticals Key News
7.19 Vaxil Bio Ltd.
7.19.1 Vaxil Bio Ltd. Corporate Summary
7.19.2 Vaxil Bio Ltd. Business Overview
7.19.3 Vaxil Bio Ltd. Covid-19 Treatment Major Product Offerings
7.19.4 Vaxil Bio Ltd. Covid-19 Treatment Revenue in Global Market (2017-2022)
7.19.5 Vaxil Bio Ltd. Key News
7.20 iBio Pharma Inc
7.20.1 iBio Pharma Inc Corporate Summary
7.20.2 iBio Pharma Inc Business Overview
7.20.3 iBio Pharma Inc Covid-19 Treatment Major Product Offerings
7.20.4 iBio Pharma Inc Covid-19 Treatment Revenue in Global Market (2017-2022)
7.20.5 iBio Pharma Inc Key News
7.21 Tonix Pharmaceuticals
7.21.1 Tonix Pharmaceuticals Corporate Summary
7.21.2 Tonix Pharmaceuticals Business Overview
7.21.3 Tonix Pharmaceuticals Covid-19 Treatment Major Product Offerings
7.21.4 Tonix Pharmaceuticals Covid-19 Treatment Revenue in Global Market (2017-2022)
7.21.5 Tonix Pharmaceuticals Key News
7.22 Curevac
7.22.1 Curevac Corporate Summary
7.22.2 Curevac Business Overview
7.22.3 Curevac Covid-19 Treatment Major Product Offerings
7.22.4 Curevac Covid-19 Treatment Revenue in Global Market (2017-2022)
7.22.5 Curevac Key News
7.23 ImmunoPrecise
7.23.1 ImmunoPrecise Corporate Summary
7.23.2 ImmunoPrecise Business Overview
7.23.3 ImmunoPrecise Covid-19 Treatment Major Product Offerings
7.23.4 ImmunoPrecise Covid-19 Treatment Revenue in Global Market (2017-2022)
7.23.5 ImmunoPrecise Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Covid-19 Treatment Market Opportunities & Trends in Global Market
Table 2. Covid-19 Treatment Market Drivers in Global Market
Table 3. Covid-19 Treatment Market Restraints in Global Market
Table 4. Key Players of Covid-19 Treatment in Global Market
Table 5. Top Covid-19 Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Covid-19 Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Covid-19 Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Covid-19 Treatment Product Type
Table 9. List of Global Tier 1 Covid-19 Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Covid-19 Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Covid-19 Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Covid-19 Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Covid-19 Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Covid-19 Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Covid-19 Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Covid-19 Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Covid-19 Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Covid-19 Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Covid-19 Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Covid-19 Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Covid-19 Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Covid-19 Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Covid-19 Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Covid-19 Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Covid-19 Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Covid-19 Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Covid-19 Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Covid-19 Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Covid-19 Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Applied DNA Sciences, Inc Corporate Summary
Table 31. Applied DNA Sciences, Inc Covid-19 Treatment Product Offerings
Table 32. Applied DNA Sciences, Inc Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Codagenix Corporate Summary
Table 34. Codagenix Covid-19 Treatment Product Offerings
Table 35. Codagenix Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GeoVax Labs, Inc. Corporate Summary
Table 37. GeoVax Labs, Inc. Covid-19 Treatment Product Offerings
Table 38. GeoVax Labs, Inc. Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Takis Biotech Corporate Summary
Table 40. Takis Biotech Covid-19 Treatment Product Offerings
Table 41. Takis Biotech Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Evvivax Corporate Summary
Table 43. Evvivax Covid-19 Treatment Product Offerings
Table 44. Evvivax Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Zydus Cadila Corporate Summary
Table 46. Zydus Cadila Covid-19 Treatment Product Offerings
Table 47. Zydus Cadila Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 48. MIGAL Galilee Research Institute Corporate Summary
Table 49. MIGAL Galilee Research Institute Covid-19 Treatment Product Offerings
Table 50. MIGAL Galilee Research Institute Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Generex Biotechnology Corporation Corporate Summary
Table 52. Generex Biotechnology Corporation Covid-19 Treatment Product Offerings
Table 53. Generex Biotechnology Corporation Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Moderna Therapeutics Corporate Summary
Table 55. Moderna Therapeutics Covid-19 Treatment Product Offerings
Table 56. Moderna Therapeutics Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Novavax Corporate Summary
Table 58. Novavax Covid-19 Treatment Product Offerings
Table 59. Novavax Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Bravovax Corporate Summary
Table 61. Bravovax Covid-19 Treatment Product Offerings
Table 62. Bravovax Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Ascletis Pharma Corporate Summary
Table 64. Ascletis Pharma Covid-19 Treatment Product Offerings
Table 65. Ascletis Pharma Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Janssen Pharmaceuticals Corporate Summary
Table 67. Janssen Pharmaceuticals Covid-19 Treatment Product Offerings
Table 68. Janssen Pharmaceuticals Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Altimmune Corporate Summary
Table 70. Altimmune Covid-19 Treatment Product Offerings
Table 71. Altimmune Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Greffex Inc. Corporate Summary
Table 73. Greffex Inc. Covid-19 Treatment Product Offerings
Table 74. Greffex Inc. Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 75. CanSino Biologics, Inc. Corporate Summary
Table 76. CanSino Biologics, Inc. Covid-19 Treatment Product Offerings
Table 77. CanSino Biologics, Inc. Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 78. ExpreS2ion Biotechnologies ApS Corporate Summary
Table 79. ExpreS2ion Biotechnologies ApS Covid-19 Treatment Product Offerings
Table 80. ExpreS2ion Biotechnologies ApS Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Clover Biopharmaceuticals Corporate Summary
Table 82. Clover Biopharmaceuticals Covid-19 Treatment Product Offerings
Table 83. Clover Biopharmaceuticals Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Vaxil Bio Ltd. Corporate Summary
Table 85. Vaxil Bio Ltd. Covid-19 Treatment Product Offerings
Table 86. Vaxil Bio Ltd. Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 87. iBio Pharma Inc Corporate Summary
Table 88. iBio Pharma Inc Covid-19 Treatment Product Offerings
Table 89. iBio Pharma Inc Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 90. Tonix Pharmaceuticals Corporate Summary
Table 91. Tonix Pharmaceuticals Covid-19 Treatment Product Offerings
Table 92. Tonix Pharmaceuticals Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 93. Curevac Corporate Summary
Table 94. Curevac Covid-19 Treatment Product Offerings
Table 95. Curevac Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
Table 96. ImmunoPrecise Corporate Summary
Table 97. ImmunoPrecise Covid-19 Treatment Product Offerings
Table 98. ImmunoPrecise Covid-19 Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Covid-19 Treatment Segment by Type in 2021
Figure 2. Covid-19 Treatment Segment by Application in 2021
Figure 3. Global Covid-19 Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Covid-19 Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Covid-19 Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Covid-19 Treatment Revenue in 2021
Figure 8. By Type - Global Covid-19 Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Covid-19 Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Covid-19 Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Covid-19 Treatment Revenue Market Share, 2017-2028
Figure 12. US Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Covid-19 Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Covid-19 Treatment Revenue Market Share, 2017-2028
Figure 24. China Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Covid-19 Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Covid-19 Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Covid-19 Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Applied DNA Sciences, Inc Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Codagenix Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GeoVax Labs, Inc. Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takis Biotech Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Evvivax Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Zydus Cadila Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. MIGAL Galilee Research Institute Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Generex Biotechnology Corporation Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Moderna Therapeutics Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novavax Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bravovax Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ascletis Pharma Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Janssen Pharmaceuticals Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Altimmune Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Greffex Inc. Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. CanSino Biologics, Inc. Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. ExpreS2ion Biotechnologies ApS Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Clover Biopharmaceuticals Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Vaxil Bio Ltd. Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. iBio Pharma Inc Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Tonix Pharmaceuticals Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Curevac Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. ImmunoPrecise Covid-19 Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
